Allergic rhinitis affects an estimated 15% of the US population and is associated with impaired quality of life. JAMA Deputy Editor Mary McGrae McDermott, MD, discusses current evidence regarding the diagnosis and treatment of allergic rhinitis with author Jonathan A. Bernstein, MD, College of Medicine, University of Cincinnati.
Related Content:
Osteoarthritis—Diagnosis and Treatment
Management of Immunotherapy-Related Toxicities
Acute Pancreatitis Part 2 of 2: Treatment
Acute Pancreatitis Part 1 of 2: Diagnosis
Racial and Ethnic Disparities in COVID-19
Pharmacologic Management of Tobacco Cessation
The Winter COVID-19 Surge in New York and Los Angeles
Glaucoma Diagnosis and Treatment
Oral Antibiotics for Appendicitis
Understanding the New SARS-CoV-2 Mutation Found in England
Next Generation Sequencing of Infectious Pathogens in Public Health and Clinical Practice (Repost)
COVID-19 Vaccine Safety–Anaphylaxis and Allergic Reactions
Patent Foramen Ovale and Secondary Stroke Prevention
Crohn Disease Management
Understanding SARS-CoV-2 Genetic Variants
Nursing Homes and COVID-19
Managing Chronic Medical Conditions for Homeless Patients Presenting to the Emergency Department
Parental Relationships with Children During COVID-19 Pandemic-Related Lockdowns
Gyms, Restaurants, Mass Transit, and Community COVID-19 Exposures
The Effect of Cannabis Intoxication on Driving Ability
Create your
podcast in
minutes
It is Free
Good Mood Revolution
JAMA Editors’ Summary
JAMA Medical News
JAMAevidence The Rational Clinical Examination
JAMA Psychiatry Author Interviews
JAMA Internal Medicine Author Interviews